|
Press Releases |
|
|
|
Wednesday, September 16, 2015 |
|
Omnicare Trust PIERS to Accrue Contingent Interest |
Omnicare, Inc. announced today that, for the quarterly interest period beginning September 15, 2015, its Trust Preferred Income Equity Redeemable Securities will, subject to the terms of the Trust PIERS, accrue contingent interest at a rate of approximately $0.15 per $50 stated liquidation amount of the Trust PIERS. more info >> |
|
Wednesday, August 19, 2015 |
|
Omnicare Announces Conversion Rate Adjustments for Convertible Notes |
Omnicare, Inc. announced today an adjustment to the conversion rate of its (i) 3.75% Convertible Senior Subordinated Notes due 2025, (ii) 3.50% Convertible Senior Subordinated Notes due 2044, (iii) 3.25% Convertible Senior Debentures due 2035 and (iv) 3.25% Convertible Senior Exchange Debentures due 2035. more info >> |
|
Friday, July 24, 2015 |
|
Omnicare Reports Second-Quarter 2015 Financial Results |
Omnicare, Inc. (NYSE: OCR) reported today financial results for its second quarter ended June 30, 2015. more info >> |
|
Saturday, June 20, 2015 |
|
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest |
Omnicare, Inc. (NYSE: OCR) (the "Company") announced today that, for the period from June 15, 2015 to September 14, 2015, its Series A and Series B Trust Preferred Income Equity Redeemable Securities will accrue contingent interest at a rate of 0.125% of the average trading price of the Trust PIERS for the five trading days ended June 11, 2015, in addition to the continued accrual of regular cash interest. more info >> |
|
Friday, May 22, 2015 |
|
Omnicare Declares Quarterly Cash Dividend |
Omnicare, Inc. (NYSE:OCR) (the "Company") today announced that its Board of Directors has approved a quarterly cash dividend of $0.22 per share on the Company's common stock, to be paid on June 30, 2015, to all stockholders of record on June 12, 2015. more info >> |
|
Thursday, April 2, 2015 |
|
Omnicare to Report First-Quarter 2015 Financial Results and Hold Conference Call on Wednesday, April 29, 2015 |
Omnicare, Inc. (NYSE:OCR) will release its financial results for the first quarter of fiscal 2015 before the market opens on Wednesday, April 29, 2015. more info >> |
|
Saturday, March 28, 2015 |
|
Omnicare Announces Conversion Rate Adjustment for Convertible Notes; Series A and Series B Trust PIERS to Accrue Contingent Interest |
Omnicare, Inc. (NYSE: OCR) (the "Company") announced today an adjustment to the conversion rate of its 3.75% Convertible Senior Subordinated Notes due 2025 (the "2025 Notes"). more info >> |
|
Friday, March 6, 2015 |
|
Omnicare's Specialty Care Group Advanced Care Scripts (ACS) to Provide Specialty Pharmacy Services for Novartis' Farydak(R) |
Advanced Care Scripts (ACS), a leading specialty pharmacy and clinical services platform of Omnicare Specialty Care Group (SCG), is proud to be part of the limited distribution network for the Novartis drug Farydak(R) (panobinostat). more info >> |
|
Tuesday, March 3, 2015 |
|
Omnicare Specialty Care Group's ACS to Provide Specialty Pharmacy Services for Bayer's Nexavar(R) (sorafenib) and Stivarga(R) (regorafenib) |
Advanced Care Scripts (ACS), a leading specialty pharmacy and clinical services platform of Omnicare's Specialty Care Group, has been chosen to dispense Bayer's Nexavar(R) (sorafenib) and Stivarga(R) (regorafenib) as part of their limited distribution networks. more info >> |
|
Thursday, February 26, 2015 |
|
Omnicare Reports Fourth-Quarter and Full-Year 2014 Financial Results; Company Provides Full-Year 2015 Guidance |
Omnicare, Inc. (NYSE:OCR) reported today financial results for its fourth quarter and full year ended December 31, 2014. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
Apr 26, 2024 15:36 HKT/SGT
|
|
|
可持续发展三大支柱引领 海通恒信ESG必答卷高分亮相
Apr 26, 2024 15:28 HKT/SGT
|
|
|
可持續發展三大支柱引領 海通恆信ESG必答卷高分亮相
Apr 26, 2024 15:25 HKT/SGT
|
|
|
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project
Apr 26, 2024 14:34: JST
|
|
|
スパークス・グループによる「宇宙フロンティア2号ファンド」の設立について
Apr 26, 2024 14:00: JST
|
|
|
中滙集團公佈2024財年中期業績
Apr 26, 2024 13:51 HKT/SGT
|
|
|
Edvantage Group Announces FY2024 Interim Results
Apr 26, 2024 13:43 HKT/SGT
|
|
|
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project
Apr 26, 2024 13:27 HKT/SGT
|
|
|
Imexpharm Corporation Hosts Shareholders, Analysts and Potential Investors at its 2024 Annual General Meeting
Apr 26, 2024 13:16 HKT/SGT
|
|
|
UK advertising reports GBP36.6bn spend in 2023
Apr 26, 2024 11:00 HKT/SGT
|
|
|
JCB enables JCB Contactless acceptance at Taichung MRT in Taiwan
Apr 26, 2024 10:00 JST
|
|
|
Jeff Martin Auctioneers to Manage Sale of Sabine Mining Company Assets for North American Coal
Apr 26, 2024 08:00 HKT/SGT
|
|
|
Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase
Apr 25, 2024 21:00 HKT/SGT
|
|
|
黑桃资本向香港红十字会捐赠艺术珠宝收藏品
Apr 25, 2024 20:53 HKT/SGT
|
|
|
黑桃資本向香港紅十字會捐贈藝術珠寶收藏品
Apr 25, 2024 20:48 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|